Barclays: Focus on QCOM, AAPL, BRCM, ARMH & Samsung in Soft Handset Climate
Get Alerts QCOM Hot Sheet
Price: $163.63 --0%
Rating Summary:
29 Buy, 21 Hold, 4 Sell
Rating Trend: Down
Today's Overall Ratings:
Up: 10 | Down: 8 | New: 5
Rating Summary:
29 Buy, 21 Hold, 4 Sell
Rating Trend: Down
Today's Overall Ratings:
Up: 10 | Down: 8 | New: 5
Join SI Premium – FREE
Barclays suggests keeping the focus on Qualcomm (Nasdaq: QCOM), Apple (Nasdaq: AAPL), Broadcom (Nasdaq: BRCM), Arm Holdings (Nasdaq: ARMH) and Samsung in the current environment. The firm has lowered its 2012/13 handset unit volume growth forecast from 8% to 6%, with checks from Apple, Samsung, HTC, Research in Motion (Nasdaq: RIMM), Nokia (NYSE: NOK), ZTE & Huawei. Barclays now sees Q2 sales forecast of approx 407 million, 10-15 million less than previously forecasted.
Analyst, Jeff Kvaal, said, "Major new launches (Galaxy S 3, iPhone 5) are contributing to channel destocking and soft sell in. Slowing macro conditions also
contribute to leaner channel inventories and slow sell through."
For Mobility, Barclays prefers QUALCOMM (Nasdaq: QCOM), despite some demand drag. For FY12, EPS estimate is lowered from $3.88 to $3.77 and FY13 from $4.45 to $4.40. Overall, longer term demand and 28nm capacity additions should remain on track and offer a healthy recovery in Q1 of FY13. Less liked names including Nokia (NYSE: NOK), RIMM, Ericsson (Nasdaq: ERIC) and HTC.
Analyst, Jeff Kvaal, said, "Major new launches (Galaxy S 3, iPhone 5) are contributing to channel destocking and soft sell in. Slowing macro conditions also
contribute to leaner channel inventories and slow sell through."
For Mobility, Barclays prefers QUALCOMM (Nasdaq: QCOM), despite some demand drag. For FY12, EPS estimate is lowered from $3.88 to $3.77 and FY13 from $4.45 to $4.40. Overall, longer term demand and 28nm capacity additions should remain on track and offer a healthy recovery in Q1 of FY13. Less liked names including Nokia (NYSE: NOK), RIMM, Ericsson (Nasdaq: ERIC) and HTC.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evotec (EVO) PT Lowered to $11 at H.C. Wainwright
- Meta Platforms Inc. (META) PT Raised to $562 at Rosenblatt, 'Squishy-ish guidance'
- Boston Scientific (BSX) PT Lowered to $85 at Mizuho
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Retail SalesRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!